HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preservation of fertility and subsequent childbirth after methotrexate treatment of placenta percreta: a case report.

AbstractINTRODUCTION:
Placenta percreta is associated with maternal morbidity and mortality. A hysterectomy is often needed to control the bleeding in such cases. However, it has been advocated that placenta percreta be managed conservatively to avoid massive pelvic bleeding and to preserve the patient's fertility. Here, we present a case of placenta percreta diagnosed by magnetic resonance imaging, and treated with systemic administration of methotrexate.
CASE PRESENTATION:
A 27-year-old nulliparous Japanese woman at 39 gestational weeks had an uncomplicated vaginal delivery of a 3244-g infant. However, her placenta was not delivered, and we could not remove it manually. Contrast-enhanced magnetic resonance imaging indicated deep myometrial invasion by placental tissue and the whole placenta was strongly enhanced. Seven days post-partum, her serum human chorionic gonadotropin level was 12,656IU/L. Our patient hoped to preserve her uterus for a future pregnancy. She therefore received 13 courses of methotrexate (50mg/week, intravenous injection). Her serum human chorionic gonadotropin level was undetectable 97 days after the first methotrexate injection. At 117 days post-partum, she had a labor-like pain every three minutes and delivered the placenta. Our patient regained normal menses and at follow-up remained in good health. Two years later, she delivered a healthy daughter.
CONCLUSION:
We should try to detect placenta percreta in high-risk patients by any means. For low-risk patients, we should give a diagnosis swiftly and control any intrauterine infection and massive bleeding.
AuthorsMasato Tamate, Motoki Matsuura, Shutaro Habata, Yushi Akashi, Ryoichi Tanaka, Shinichi Ishioka, Toshiaki Endo, Tsuyoshi Saito
JournalJournal of medical case reports (J Med Case Rep) Vol. 9 Pg. 232 (Oct 19 2015) ISSN: 1752-1947 [Electronic] England
PMID26480940 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Chorionic Gonadotropin
  • Oxytocics
  • Methotrexate
Topics
  • Adult
  • Chorionic Gonadotropin (blood)
  • Female
  • Fertility (physiology)
  • Humans
  • Magnetic Resonance Imaging
  • Methotrexate (administration & dosage)
  • Oxytocics (administration & dosage)
  • Placenta Accreta (diagnosis, drug therapy)
  • Postpartum Period
  • Pregnancy
  • Term Birth

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: